Earnings-backed filing view

BOSTON SCIENTIFIC CORP (BSX)

See the latest BSX earnings framing tied back to the filing, including recent revenue and EPS trend context.

Healthcare 10-K Next earnings Date not scheduled

AI filing summary

BOSTON SCIENTIFIC CORP earnings insights

The filing reads constructive based on revenue and statement momentum.

The latest 10-K for BSX shows revenue was $20.1B.

Key changes

What stands out in the latest report

  • Revenue moved to $20.1B from $16.7B (+19.9% vs prior).
  • Diluted EPS moved to $1.94 from $1.25 (+55.2% vs prior).
  • Cash & equivalents moved to $2.0B from $1.3B (+54.1% vs prior).

Current read

Positive read

Financial snapshot

Latest reported figures

Revenue $20.1B
Net income N/A
EPS $1.94
Operating cash flow $4.5B

Trend section

Recent revenue trend

Q3 $4.2B

Period ended 2024-09-30

Q1 $4.7B

Period ended 2025-03-31

Q2 $5.1B

Period ended 2025-06-30

Q3 $5.1B

Period ended 2025-09-30

Trend section

Recent EPS trend

Q3 N/A

Filed period trend snapshot.

Q1 N/A

Filed period trend snapshot.

Q2 N/A

Filed period trend snapshot.

Q3 N/A

Filed period trend snapshot.

Related links

Move through the research workflow

Related companies

Read-throughs worth checking